Improved detection of breast cancer on FDG-PET cancer screening using breast positioning device

Annals of Nuclear Medicine

Volumn 22, Issue 2, 2008, Pages 95-101

  Kaida, Hayato ^a   Ishibashi, Masatoshi ^a   Fujii, Teruhiko ^a   Kurata, Seiji ^a   Ogo, Etsuyo ^a   Tanaka, Maki ^b   Hayabuchi, Naofumi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Surgery   (Japan)

Author keywords

Breast cancer; Breast positioning device; Cancer screening; Fluorine 18 fluorodeoxyglucose positron emission tomography; Prone position

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BODY POSTURE; BREAST; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER RESEARCH; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR VOLUME; WHOLE BODY IMAGING;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CLINICAL PROTOCOLS; EQUIPMENT FAILURE ANALYSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PRONE POSITION; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SUPINE POSITION; WHOLE BODY IMAGING;

EID: 40149105402     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-007-0092-1     Document Type: Article

References (27)

1. Czernin J. FDG-PET in breast cancer: a different view of its clinical usefulness. Mol Imaging Biol 2002;4:35-42.
2. Schirrmeister H, Kuhn T, Guhlmann A, Santjohanser C, Horster T, Nussle K, et al. Fluorine-18 2-deoxy-2-fluoro-d-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med 2001;28:351-358.
3. Eubank WB, Mankoff D, Bhattacharya M, Gralow J, Linden H, Ellis G, et al. Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrence or metastatic breast cancer. AJR Am J Roentogenol 2004;183:479-486.
4. Dose Schwarz J, Bader M, Jenicke L, Hemminger G, Janicke F, Avril N. Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET. J Nucl Med 2005;46:1144-1150.
5. Kuehl H, Veit P, Rosenbarum SJ, Bockisch A, Antoch G. Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen. J Nucl Med 2007;48Suppl:45-57.
6. Sobin LH, Wittekindt C (International Union Aginest Cancer UICC), editors. TMN classification of malignant tumors. 6th ed. Baltimore: Wiley-Liss; 2002. p. 131-140.
7. Tabar L. Control of breast cancer through screening mammography. Radiology 1996;174:655-656.
8. Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993;17:973-978.
9. Eckhardt S, Badellino F, Murphy GP. UICC meeting on breast cancer screening in premenopausal women in developed countries. Int J Cancer 1994;56:1-5.
10. Moss SM. Breast cancer. In: Kramer BS, Gohagan JK, Prorok PC, editors. Cancer screening, New York: Marcel Dekker; 1999. p. 143-193.
11. Yasuda S, Ide M. PET and cancer screening. Ann Nucl Med 2005;19:167-177.
12. Ide M. Cancer screening with FDG-PET. Q J Nucl Med Mol Imaging 2006;50:23-27.
13. Chen YK, Ding HJ, Su CT, Shen YY, Chen LK, Liao AC, et al. Application of PET and PET/CT imaging for cancer screening. Anticancer Res 2004;24:4103-4108.
14. Ide M, Suzuki Y. Is whole-body FDG-PET valuable for health screening? For Eur J Nucl Med Mol Imaging 2005;32:339-341.
15. Yasuda S, Ide M, Fujii H, Nakahara T, Mochizuki Y, Takahashi W, et al. Application of positron emission tomography imaging to cancer screening. Br J Cancer 2000;83:1607-1611.
16. Khalkhali I, Cutrone J, Mena IG, Diggles LE, Venegas RJ, Vargas HI, et al. Technetium-99m-senstamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995;36:1784-1789.
17. Taillefer R, Robidoux A, Lambert R, Turupin S, Laperriere J. Technetium-99m-senstamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-1765.
18. Villaueva-Meyer J, Leonard MH Jr, Briscoe E, Cesani F, Ali SA, Rhoden S, et al. Mammography with technetium-99m-senstamibi in suspected breast cancer. J Nucl Med 1996;37:926-930.
19. Palmedo H, Biersack HJ, Lastoria S, Maublant J, Pratz E, Stegner HE, et al. Scintimammography with technetium-99m methoxy isobutylisonitrile; results of prospective European multicentre trial. Eur J Nucl Med 1998;25:375-385.
20. Avril N, Bense S, Ziegler S, Dose J, Kuhn W, Bense J, et al. Breast imaging with fluorine-18 FDG PET: quantitative image analysis. J Nucl Med 1997;38:1186-1191.
21. Lind P, Igerc I, Beyer T, Reinprecht P, Hausegger K. Advantages and limitations of FDG PET in the follow-up of breast cancer. Eur J Nucl Med Mol Imaging 2004;31Suppl:125-134.
22. Adler LP, Crowe JP, Al-Kaisi NK, Sunshin JL. Evaluation of breast masses and axillary lymph nodes with [F-18]-2-deoxy-d-glucose PET. Radiology 1993;187:743-750.
23. Avril N, Dose J, Janicke F, Bense S, Ziegler S, Lautenbacher C, et al. Metabolic characterization of breast tumors with positron emission tomography using [F-18]-flurodeoxyglucose. J Clin Oncol 1996;14:1848-1857.
24. Yutani K, Shiba E, Kusuoka H, Tatsumi M, Uehara T, Taguchi T, et al. Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis. J Comput Assist Tomogr 2000;24:274-280.
25. Kumar R, Loving VA, Chauhan A, Zhuang H, Mitchell S, Alavi A. Potential of dual-time-point imaging to improve breast cancer diagnosis with (18) F-FDG-PET. J Nucl Med 2005;46:1819-1824.
26. Mavi A, Urhan M, Yu JQ, Zhuang H, Houseni M, Cermik TF, et al. Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. J Nucl Med 2006;47:1440-1446.
27. Heinisch M, Gallowitsch HJ, Mikosch P, Kresnik E, Kumnig G, Gomez I, et al. Comparison of FDG-PET and dynamic contrast-enhanced MRI in the evaluation of suggestive breast lesions. Breast 2003;12:17-22.